Khokhar, Jibran Y. Dwiel, Lucas L. Henricks, Angela M. Doucette, Wilder T. and Green, Alan I. 2018. The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research, Vol. 194, p. 78.
Halldorsdottir, Thorhildur and Binder, Elisabeth B. 2017. Gene × Environment Interactions: From Molecular Mechanisms to Behavior. Annual Review of Psychology, Vol. 68, Issue. 1, p. 215.
Hassunah, Rawan and McIntosh, James 2016. Quality of Life and Cannabis Use: Results from Canadian Sample Survey Data. Health, Vol. 08, Issue. 14, p. 1576.
Henchoz, Yves N’Goran, Alexandra A. Baggio, Stéphanie Deline, Stéphane Studer, Joseph and Gmel, Gerhard 2016. Associations of age at cannabis first use and later substance abuse with mental health and depression in young men. Journal of Substance Use, Vol. 21, Issue. 1, p. 85.
Vreeker, A. Boks, M. P. M. Abramovic, L. Verkooijen, S. van Bergen, A. H. Hillegers, M. H. J. Spijker, A. T. Hoencamp, E. Regeer, E. J. Riemersma-Van der Lek, R. F. Stevens, A. W. M. M. Schulte, P. F. J. Vonk, R. Hoekstra, R. van Beveren, N. J. M. Kupka, R. W. Brouwer, R. M. Bearden, C. E. MacCabe, J. H. and Ophoff, R. A. 2016. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls. Psychological Medicine, Vol. 46, Issue. 04, p. 807.
Vermeulen-Smit, Evelien Verdurmen, J. E. E. and Engels, R. C. M. E. 2015. The Effectiveness of Family Interventions in Preventing Adolescent Illicit Drug Use: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Child and Family Psychology Review, Vol. 18, Issue. 3, p. 218.
Schlier, Björn Jaya, Edo S. Moritz, Steffen and Lincoln, Tania M. 2015. The Community Assessment of Psychic Experiences measures nine clusters of psychosis-like experiences: A validation of the German version of the CAPE. Schizophrenia Research, Vol. 169, Issue. 1-3, p. 274.
Bagot, Kara S. Milin, Robert and Kaminer, Yifrah 2015. Adolescent Initiation of Cannabis Use and Early-Onset Psychosis. Substance Abuse, Vol. 36, Issue. 4, p. 524.
Niesink, Raymond J. M. Rigter, Sander Koeter, Maarten W. and Brunt, Tibor M. 2015. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15. Addiction, Vol. 110, Issue. 12, p. 1941.
van Amsterdam, Jan Brunt, Tibor and van den Brink, Wim 2015. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology, Vol. 29, Issue. 3, p. 254.
van Gastel, W.A. Vreeker, A. Schubart, C.D. MacCabe, J.H. Kahn, R.S. and Boks, M.P.M. 2014. Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences. Schizophrenia Research, Vol. 157, Issue. 1-3, p. 266.
Vleeschouwer, Marloes Schubart, Chris D. Henquet, Cecile Myin-Germeys, Inez van Gastel, Willemijn A. Hillegers, Manon H. J. van Os, Jim J. Boks, Marco P. M. Derks, Eske M. and Miles, Jeremy 2014. Does Assessment Type Matter? A Measurement Invariance Analysis of Online and Paper and Pencil Assessment of the Community Assessment of Psychic Experiences (CAPE). PLoS ONE, Vol. 9, Issue. 1, p. e84011.
Ajnakina, Olesya Borges, Susana Di Forti, Marta Patel, Yogen Xu, Xiaohui Green, Priscilla Stilo, Simona A. Kolliakou, Anna Sood, Poonam Marques, Tiago Reis David, Anthony S. Prata, Diana Dazzan, Paola Powell, John Pariante, Carmine Mondelli, Valeria Morgan, Craig Murray, Robin M. Fisher, Helen L. and Iyegbe, Conrad 2014. Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis. Frontiers in Psychiatry, Vol. 5,
Wu, Li-Tzy Brady, Kathleen T. Mannelli, Paolo and Killeen, Therese K. 2014. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: A national study. Journal of Psychiatric Research, Vol. 50, p. 26.
Di Forti, M. Sallis, H. Allegri, F. Trotta, A. Ferraro, L. Stilo, S. A. Marconi, A. La Cascia, C. Reis Marques, T. Pariante, C. Dazzan, P. Mondelli, V. Paparelli, A. Kolliakou, A. Prata, D. Gaughran, F. David, A. S. Morgan, C. Stahl, D. Khondoker, M. MacCabe, J. H. and Murray, R. M. 2014. Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users. Schizophrenia Bulletin, Vol. 40, Issue. 6, p. 1509.
Nijs, Miesje M. Bun, Clothilde J. E. Tempelaar, Wanda M. de Wit, Niek J. Burger, Huibert Plevier, Carolien M. and Boks, Marco P. M. 2014. Perceived School Safety is Strongly Associated with Adolescent Mental Health Problems. Community Mental Health Journal, Vol. 50, Issue. 2, p. 127.
Szoke, Andrei Galliot, Anne-Marie Richard, Jean-Romain Ferchiou, Aziz Baudin, Grégoire Leboyer, Marion and Schürhoff, Franck 2014. Association between cannabis use and schizotypal dimensions – A meta-analysis of cross-sectional studies. Psychiatry Research, Vol. 219, Issue. 1, p. 58.
Huijbregts, Stephan C. J. Griffith-Lendering, Merel F. H. Vollebergh, Wilma A. M. and Swaab, Hanna 2014. Neurocognitive moderation of associations between cannabis use and psychoneuroticism. Journal of Clinical and Experimental Neuropsychology, Vol. 36, Issue. 8, p. 794.
Schubart, C.D. Sommer, I.E.C. Fusar-Poli, P. de Witte, L. Kahn, R.S. and Boks, M.P.M. 2014. Cannabidiol as a potential treatment for psychosis. European Neuropsychopharmacology, Vol. 24, Issue. 1, p. 51.
Cannabis use is associated with psychosis and a range of subclinical psychiatric symptoms. The strength of this association depends on dosage and age at first use. The current study investigates whether level of cannabis exposure and starting age are associated with specific profiles of subclinical symptoms.
We collected cross-sectional data from a young adult population sample by administering an online version of the Community Assessment of Psychic Experiences (CAPE). Cannabis exposure was quantified as the amount of Euros spent on cannabis per week and the age of initial cannabis use. The primary outcome measure was the odds ratio (OR) to belong to the highest 10% of scores on the total CAPE and the positive-, negative- and depressive symptom dimensions.
In 17 698 adolescents (mean age 21.6, s.d.=4.2 years), cannabis use at age 12 years or younger was strongly associated with a top 10% score on psychotic experiences [OR 3.1, 95% confidence interval (CI) 2.1–4.3] and to a lesser degree with negative symptoms (OR 1.7, 95% CI 1.1–2.5). The OR of heavy users (>€25/week) for negative symptoms was 3.4 (95% CI 2.9–4.1), for psychotic experiences 3.0 (95% CI 2.4–3.6), and for depressive symptoms 2.8 (95% CI 2.3–3.3).
Early start of cannabis use is strongly associated with subclinical psychotic symptoms and to a lesser degree with negative symptoms, while smoking high amounts of cannabis is associated with increased levels of all three symptom dimensions: psychotic, negative and depressive. These results support the hypothesis that the impact of cannabis use is age specific.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 25th May 2018. This data will be updated every 24 hours.